NALLPEN Drug Patent Profile
✉ Email this page to a colleague
When do Nallpen patents expire, and what generic alternatives are available?
Nallpen is a drug marketed by Glaxosmithkline and Baxter Hlthcare and is included in three NDAs.
The generic ingredient in NALLPEN is nafcillin sodium. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the nafcillin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nallpen
A generic version of NALLPEN was approved as nafcillin sodium by ISTITUTO BIO ITA SPA on April 20th, 2011.
Summary for NALLPEN
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 32 |
Patent Applications: | 5,541 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NALLPEN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for NALLPEN
US Patents and Regulatory Information for NALLPEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | NALLPEN | nafcillin sodium | INJECTABLE;INJECTION | 061999-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Baxter Hlthcare | NALLPEN IN PLASTIC CONTAINER | nafcillin sodium | INJECTABLE;INJECTION | 050655-002 | Oct 31, 1989 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline | NALLPEN | nafcillin sodium | INJECTABLE;INJECTION | 062755-002 | Dec 19, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Baxter Hlthcare | NALLPEN IN PLASTIC CONTAINER | nafcillin sodium | INJECTABLE;INJECTION | 050655-001 | Oct 31, 1989 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |